Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Switzerland ,Swiss ,Esteban Rodrigo Imedio ,Stephen Barr ,Prnewswire Debiopharm ,Head Of Communications ,Jp Morgan ,Debiopharm International ,Oncology Research Development ,Senior Medical Director ,Oncology Research ,Almac Discovery ,Managing Director ,Business ,Health ,Cancer ,Tumors ,Pr Newswire ,Europe ,